| DB ID | MyCo_2490 |
| Title | A pilot study on nasal wash galactomannan as a surrogate marker for invasive aspergillosis among hematology patients in Thailand |
| Year | 2024 |
| PMID | 39592659 |
| Fungal Diseases involved | Invasive aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | The study, conducted in accordance with the amended Declaration of Helsinki, received approval from the Ethics Committee of Ramathibodi Hospital, Bangkok, Thailand (approval no. MURA 2021/125). The committee approved the use of patient samples and data for this study’s publication. Written consent was obtained from all participants. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Nasal wash fluid |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Thailand |
| Cohort | The study included 34 patients, of which 20 were female (58.8%). The median age of the participants was 50.5 years (IQR 36.5–58). |
| Cohort No. | 34 |
| Age Group | 36.5–58 |
| P Value | None |
| Sensitivity | 0.4 |
| Specificity | 0.8 |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit- Platelia Aspergillus (Platelia™ Aspergillus Ag, Bio-Rad Laboratories, Hercules, CA, USA) |
| Assay Data | None |
| Validation Techniques used | FDA Approved -Platelia Aspergillus ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
